JOSEPH JANKOVIC to Parkinson Disease, Secondary
This is a "connection" page, showing publications JOSEPH JANKOVIC has written about Parkinson Disease, Secondary.
Connection Strength
2.314
-
Drug-induced parkinsonism: diagnosis and treatment. Expert Opin Drug Saf. 2024 Dec; 23(12):1503-1513.
Score: 0.922
-
Deep brain stimulation of the subthalamic nucleus for peripherally induced parkinsonism. Neuromodulation. 2014 Jan; 17(1):104-6.
Score: 0.417
-
F-box only protein 7 gene in parkinsonian-pyramidal disease. JAMA Neurol. 2013 Jan; 70(1):20-4.
Score: 0.406
-
MDMA and Parkinsonism. N Engl J Med. 2003 Jul 03; 349(1):96-7.
Score: 0.210
-
Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease. J Neurochem. 2010 Oct; 115(1):188-99.
Score: 0.086
-
Progressive supranuclear palsy: motor, neurobehavioral, and neuro-ophthalmic findings. Adv Neurol. 1990; 53:293-304.
Score: 0.083
-
Parkinsonism-plus syndromes. Mov Disord. 1989; 4 Suppl 1:S95-119.
Score: 0.077
-
Neurologic approach to drug-induced movement disorders: a study of 125 patients. South Med J. 1990 May; 83(5):525-32.
Score: 0.021
-
Metoclopramide-induced movement disorders. Clinical findings with a review of the literature. Arch Intern Med. 1989 Nov; 149(11):2486-92.
Score: 0.020
-
Parkinson's disease: recent advances in therapy. South Med J. 1988 Aug; 81(8):1021-7.
Score: 0.019
-
Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias. Neurology. 1988 Mar; 38(3):391-4.
Score: 0.018
-
Coexistent tardive dyskinesia and parkinsonism. Clin Neuropharmacol. 1987 Dec; 10(6):511-21.
Score: 0.018
-
Tardive myoclonus. Mov Disord. 1987; 2(4):307-11.
Score: 0.017